IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer
RNA-seq (gene expression) · human · 25 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 25 samples: 9 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE297633_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1265496 and SRA study SRP587462. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 8 samples read as cases, 2 as controls.
How we read this: 9 replicated groups read from 25 sample titles; they account for 25 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8995913 LNCaP, full media, 72hours, 1 LNCaP, full media, 72ho…
- GSM8995914 LNCaP, full media, 72hours, 2 LNCaP, full media, 72ho…
- GSM8995915 LNCaP, full media, 72hours, 3 LNCaP, full media, 72ho…
- GSM8995916 LNCaP, Charcoal Stripped Media, 72 hours, 1 LNCaP, Charcoal Strippe…
- GSM8995917 LNCaP, Charcoal Stripped Media, 72 hours, 2 LNCaP, Charcoal Strippe…
- GSM8995918 LNCaP, Charcoal Stripped Media, 72 hours, 3 LNCaP, Charcoal Strippe…
- GSM8995919 LNCaP, DMSO, 12 hours, 1 LNCaP, DMSO, 12 hours,
- GSM8995920 LNCaP, DMSO, 12 hours, 2 LNCaP, DMSO, 12 hours,
- GSM8995921 LNCaP, Ethanol, 12 hours, 1 LNCaP, Ethanol, 12 hour…
- GSM8995922 LNCaP, Ethanol, 12 hours, 2 LNCaP, Ethanol, 12 hour…
- GSM8995923 LNCaP, Ethanol, 12 hours, 3 LNCaP, Ethanol, 12 hour…
- GSM8995924 LNCaP, R1881, 12 hours, 1 LNCaP, R1881, 12 hours,
- GSM8995925 LNCaP, R1881, 12 hours, 2 LNCaP, R1881, 12 hours,
- GSM8995926 LNCaP, R1881, 12 hours, 3 LNCaP, R1881, 12 hours,
- GSM8995927 LNCaP, Enzalutamide, 12 hours, 1 LNCaP, Enzalutamide, 12…
- GSM8995928 LNCaP, Enzalutamide, 12 hours, 2 LNCaP, Enzalutamide, 12…
- GSM8995929 LNCaP, Enzalutamide, 12 hours, 3 LNCaP, Enzalutamide, 12…
- GSM8995930 LNCaP, IRE1 knockout, full media, 72 hours, 1 LNCaP, IRE1 knockout, f…
- GSM8995931 LNCaP, IRE1 knockout, full media, 72 hours, 2 LNCaP, IRE1 knockout, f…
- GSM8995932 LNCaP, IRE1 knockout, Charcoal Stripped Media, 72 hours, 1 LNCaP, IRE1 knockout, C…
- GSM8995933 LNCaP, IRE1 knockout, Charcoal Stripped Media, 72 hours, 2 LNCaP, IRE1 knockout, C…
- GSM8995934 LNCaP, IRE1 knockout, Charcoal Stripped Media, 72 hours, 3 LNCaP, IRE1 knockout, C…
- GSM8995935 LNCaP, IRE1 knockout, Enzalutamide, 12 hours, 1 LNCaP, IRE1 knockout, E…
- GSM8995936 LNCaP, IRE1 knockout, Enzalutamide, 12 hours, 2 LNCaP, IRE1 knockout, E…
- GSM8995937 LNCaP, IRE1 knockout, Enzalutamide, 12 hours, 3 LNCaP, IRE1 knockout, E…
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE268308 Transcriptional analysis of metastatic hormone-naïve prostate cancer primary tumour biopsies reveals a relevant role for SOX11 in prostate cancer cell dissemination [Discovery dataset] 78 samples shares metastatic, prostate
- GSE237876 Deciphering metastatic route-specific signals and their microenvironment interactions in peritoneal metastasis of gastric cancer 66 samples shares microenvironment, metastatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.